Efficacy of brexpiprazole on frequently occurring agitation behaviors in patients with dementia due to Alzheimer’s disease: post hoc pooled analysis of two randomized controlled trials

Malaak Brubaker, David Wang, Sanjeda R Chumki, Pedro Such, Zhen Zhang, Anton M Palma · 2025

Read Efficacy of brexpiprazole on frequently occurring agitation behaviors in patients with dementia due to Alzheimer’s disease: post hoc pooled analysis of two randomized controlled trials by Malaak Brubaker, David Wang, Sanjeda R Chumki, Pedro Such, Zhen Zhang, Anton M Palma (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11709518.txt.

Description

Malaak Brubaker and five co-authors wrote a 2025 study of how the drug brexpiprazole affects specific behaviors in Alzheimer's dementia. The behaviors range from pacing to verbal and physical aggression, and each one crops up at its own rate. An old study scored all 29 of them on a standard inventory. This one zooms in on people who showed each one often at the start.

Data came from two twelve-week, placebo-controlled trials of fixed doses of the drug. The team checked how each score changed by week twelve, drug against placebo. A focus on those hit most often tests the drug where the strain is worst. This view adds to the old one, which covered all who took part. The inventory scores each act from never to a few times an hour. The work may help doctors pick care for the acts families find hardest.

Catalog record

CREATORMalaak Brubaker, David Wang, Sanjeda R Chumki, Pedro Such, Zhen Zhang, Anton M Palma
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11709518

Browse the full library · About the Tower of Babel